CVET Covetrus Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CVET

Price (delayed)

$36.17

Market cap

$4.61B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.97

Enterprise value

$5.39B

Sector: Healthcare
Industry: Health Information Services

Highlights

The net income has soared by 90% QoQ and by 89% YoY
Covetrus's EPS has soared by 89% from the previous quarter and by 88% YoY
CVET's quick ratio has soared by 58% year-on-year but it is down by 3.8% since the previous quarter
CVET's gross margin is down by 2.7% year-on-year

Key stats

What are the main financial stats of CVET
Market
Shares outstanding
127.52M
Market cap
$4.61B
Enterprise value
$5.39B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.88
Price to sales (P/S)
0.99
EV/EBIT
673.16
EV/EBITDA
27.34
EV/Sales
1.27
Earnings
Revenue
$4.23B
EBIT
$8M
EBITDA
$197M
Free cash flow
$36M
Per share
EPS
-$0.97
Free cash flow per share
$0.31
Book value per share
$12.55
Revenue per share
$36.42
TBVPS
$15.65
Balance sheet
Total assets
$3.51B
Total liabilities
$1.99B
Debt
$1.13B
Equity
$1.42B
Working capital
$769M
Liquidity
Debt to equity
0.8
Current ratio
2.05
Quick ratio
1.28
Net debt/EBITDA
3.92
Margins
EBITDA margin
4.7%
Gross margin
18.1%
Net margin
-2.5%
Operating margin
-1.8%
Efficiency
Return on assets
-3%
Return on equity
-8.1%
Return on invested capital
0.4%
Return on capital employed
0.3%
Return on sales
0.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CVET stock price

How has the Covetrus stock price performed over time
Intraday
-4.41%
1 week
-1.04%
1 month
14.5%
1 year
149.97%
YTD
25.85%
QTD
25.85%

Financial performance

How have Covetrus's revenue and profit performed over time
Revenue
$4.23B
Gross profit
$763M
Operating income
-$76M
Net income
-$104M
Gross margin
18.1%
Net margin
-2.5%
Covetrus's operating margin has surged by 93% QoQ and by 93% YoY
CVET's operating income has soared by 92% since the previous quarter and by 92% year-on-year
The net margin has soared by 90% from the previous quarter and by 90% YoY
The net income has soared by 90% QoQ and by 89% YoY

Growth

What is Covetrus's growth rate over time

Valuation

What is Covetrus stock price valuation
P/E
N/A
P/B
2.88
P/S
0.99
EV/EBIT
673.16
EV/EBITDA
27.34
EV/Sales
1.27
Covetrus's EPS has soared by 89% from the previous quarter and by 88% YoY
The P/B is 106% above the last 4 quarters average of 1.4
The company's equity rose by 11% QoQ and by 7% YoY
The P/S is 148% more than the last 4 quarters average of 0.4
Covetrus's revenue has increased by 9% YoY and by 2.6% from the previous quarter

Efficiency

How efficient is Covetrus business performance
Covetrus's ROS has soared by 101% from the previous quarter and by 101% YoY
The company's return on invested capital has surged by 101% QoQ and by 101% YoY
The return on equity has surged by 90% since the previous quarter and by 84% year-on-year
The ROA has soared by 90% from the previous quarter and by 89% YoY

Dividends

What is CVET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CVET.

Financial health

How did Covetrus financials performed over time
CVET's total assets is 76% greater than its total liabilities
CVET's quick ratio has soared by 58% year-on-year but it is down by 3.8% since the previous quarter
The debt is 20% less than the equity
The company's equity rose by 11% QoQ and by 7% YoY
The debt to equity has declined by 10% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.